The Evolution of Surgical Techniques for Critical Limb Ischemia

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

0 comments

Post a comment

    Post a comment
    Embed Video
    Edit your comment Cancel

    Favorites, Groups & Events

    The Evolution of Surgical Techniques for Critical Limb Ischemia - Presentation Transcript

    1. The Evolution of Surgical Techniques for Critical Limb Ischemia Cameron M. Akbari, M.D., M.B.A., F.A.C.S. Washington Hospital Center Washington, D.C.
    2. Principles of Limb Salvage for Tissue Loss 1. Prompt control of infection - drainage, antibiotics. 2. Evaluation for ischemia. 3. Timely arterial reconstruction if ischemia present, restore maximal perfusion to the foot. 4. Secondary foot procedures in the fully, maximally revascularized foot.
    3. Tissue Loss: Revascularization and Choice of Target Artery 1. Restore maximum perfusion to the foot whenever possible. 2. Preferred target: the first vessel in continuity with the foot, to provide pulsatile maximal flow. 3. Available autogenous conduit may limit the choice of target artery for bypass options. 4. Revascularization should be planned with alternative target and inflow arteries in mind: plan A, plan B, etc.
    4. Open Bypass for Tissue Loss  The standard – hundreds of reports  Really good operation in the right hands  Excellent patency from some centers  Can be done well in multiple patient populations, octogenarians, multiple medical problems, using complex conduits  Most success measured in patency and limb salvage
    5. Lower Extremity Arterial Intervention: General Principles Inflow (proximal to inguinal ligament) Conduit Outflow
    6. Vascular Intervention: Inflow Operations Aorto-Bifemoral Bypass Ilio-Femoral Bypass Femoral-Femoral Bypass Axillo-Femoral Bypass
    7. Aorto-Bifemoral Bypass: Exposure
    8. Aorto-Bifemoral Bypass: Exposure
    9. Aorto-Bifemoral Bypass End to End to end side
    10. Aorto-Bifemoral Bypass: Aortic Anastomosis
    11. Aorto-Bifemoral Bypass: Femoral Anastomosis
    12. Axillo-Bifemoral Bypass: Axillary Anastomosis
    13. Axillo-Bifemoral Bypass: Femoral Anastomosis
    14. Axillo-Bifemoral Bypass: Cross-Femoral
    15. Inflow Operations: Results Operation Five-year 1° Patency Aorto-bifemoral 90% Ilio-femoral 70-85% Femoral-femoral 60-85% Axillo-bifemoral 40-80% Axillo-unifemoral 20-50%
    16. Lower Extremity Bypass Reversed Vein Graft Nonreversed (Translocated) Vein Graft In Situ Vein Graft Prosthetic Composite Prosthetic/Vein Graft
    17. Lower Extremity Bypass: General Principles Superior Patency of GSV Grafts Autogenous Grafts Preferred over Prosthetic High Quality Conduit is Key to Success
    18. In Situ Leg Bypass: Vein Preparation Femoral vein GSV
    19. In Situ Bypass: Valve Lysis
    20. Angioscopy Angioscopic Vein Graft Preparation Valve Valvulotome Lysed Valve
    21. Lower Extremity Bypass: Anastomoses Proximal anastomosis Distal anastomosis
    22. Lower Extremity Bypass: QUOTED 5 Year Patency Rates – GSV Above Knee: 80% Below Knee Popliteal: 70% Infrageniculate (Tibial): 60% Paramalleolar: 55% OVERALL: 50 - 70%
    23. Lower Extremity Bypass: One Year Results PREVENT III Multi Center Trial Survival: 80% Primary Patency: 70% Primary Assisted Patency: 60% Secondary Patency: 55% 1404 patients w/ CLI All autogenous conduit “High risk” conduit in 24% 65% infrapopliteal Conte et al. J Vasc Surg 2006; 43: 742-751
    24. Bypass 100 100 90 90 Cumulative Survival 80 80 Limb Salvage 70 70 60 60 50 50 40 40 30 DM patients 30 DM patients 20 non-DM patients 20 non-DM patients 10 10 0 0 0 10 20 30 40 50 60 0 10 20 30 40 50 60 Time (months) Time (months) Akbari, et al. Arch Surg 2000
    25. “Successful” Bypass
    26. Open Bypass for Tissue Loss  The standard – hundreds of reports  Excellent patencies from some centers  Can be done well in multiple patient populations, octagenarians, multiple medical problems, using complex conduits  Most success measured in patency and limb salvage  Function? Back to work? Rehab?
    27. Quality of Life and Infrainguinal Bypass 1. Tremendous variation between reports - mortality, perioperative morbidity 2. At least 3 - 6 months for healing of the foot 3. Most patients return to pre-op status (non- ambulatory patients remain non-ambulatory) 4. Approximately 40-50% of patients report “back to normal” at 6 months
    28. Quality of Life and Infrainguinal Bypass 5. Improvement in symptom outcome measures: healing of foot ulcers, improved pain measures 6. Better function before bypass is associated with better function after bypass 7. 75% - 85% of patients who are independent pre-op remain independent post-op. 8. Limb amputation (after failed bypass) is associated with the lowest quality of life scores.
    29. Another alternative..
    30. Lower Extremity Endovascular Interventions: More Options than Ever  POBA  Stenting  Laser Assisted Angioplasty  Atherectomy  Subintimal Angioplasty  Cryoplasty  DES
    31. Infrainguinal Endovascular Procedures Changing Paradigm – Endovascular  Endovascular methods rapidly advancing  Immediate symptom relief for claudicators  Excellent immediate success  Encouraging long-term patency and limb salvage, paralleling surgical results, from some centers  But…
    32. “Successful Endo”
    33. “Successful” Endo 1 Month later
    34. So… Endovascular versus Open Bypass for Tissue Loss: HOW TO DECIDE
    35. Endovascular versus Open Bypass: Choice  Patient Considerations  Lesion Considerations  One Other Consideration The test of a first rate intelligence is the ability to hold two opposed ideas in mind at the same time and still retain the ability to function. - F. Scott Fitzgerald
    36. Endovascular versus Open Bypass: Patient General Considerations  Functional Status  Ambulatory, Non-ambulatory, Bedridden  Co-morbidities  Differentiate between significant and non-significant  Diabetes
    37. Endovascular versus Open Bypass: Patient Specific Considerations  Availability of Conduit  Ipsilateral Saphenous Vein  Status of other leg and contralateral GSV  Degree of Tissue Loss Can you restore pulsatile flow? Can you afford not to?
    38. Endovascular versus Open Bypass: Lesion Considerations: The “L’s”  Location  Iliac, Femoro-popliteal, Tibial  Length  Lumen  Occlusion vs. Stenosis; Calcified  Levels – multilevel vs. single level  Likelihood of short, intermediate, long-term patency
    39. 64 yo ambulatory independent woman with ESRD, known CAD, right forefoot gangrene – needs TMA
    40. 64 yo ambulatory independent woman with ESRD, known CAD, right forefoot gangrene – needs TMA
    41. 64 yo ambulatory independent woman with ESRD, known CAD, right forefoot gangrene – needs TMA
    42. Bypass versus Endovascular: Look at the Patient, not just the foot
    43. 94 yo ambulatory independent man, healthy except for mild diabetes, foot ulcer – needs arthroplasty
    44. Follow up 2 month Duplex
    45. 64 yo diabetic man with one year history of foot ulcer. Fully ambulatory.
    46. 1 year
    47. 6 month Follow up Duplex * *Foot remains healed one year later
    48. Endovascular versus Open Bypass: One Other Consideration..
    49. A man's got to know his limitations. Harry Callahan 1973
    50. Bypass vs. Endo * * # # *61% w/ tissue loss Kudo et al. JVS 2006; 44: 304-313 # 68% w/ tissue loss
    51. Bypass vs. Endo * Primary patency < 20% at 5 years Kudo et al. JVS 2006; 44: 304-313
    52. Bypass versus Endo Pomposelli, et al. J Vasc Surg 2003
    53. Summary  Endovascular procedures below the inguinal ligament are here to stay, and the applications and results are improving every day. The results are excellent in the right hands.  Open bypass procedures below the inguinal ligament are here to stay. The results are excellent in the right hands.
    54. Summary  The choice between open and endovascular revascularization is based on multiple considerations, weighed together.
    55. Summary  Open versus endovascular procedures for tissue loss is not appropriate.  Rather, we should be talking about open and endovascular procedures, as in (e.g.) statins and beta blockers.
    56. Thank You

    + New Cardiovascular HorizonsNew Cardiovascular Horizons, 5 months ago

    custom

    199 views, 0 favs, 0 embeds more stats

    Presented by Cameron Akbari, MD at New Cardiovascul more

    More info about this document

    © All Rights Reserved

    Go to text version

    • Total Views 199
      • 199 on SlideShare
      • 0 from embeds
    • Comments 0
    • Favorites 0
    • Downloads 9
    Most viewed embeds

    more

    All embeds

    less

    Flagged as inappropriate Flag as inappropriate
    Flag as inappropriate

    Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

    Cancel
    File a copyright complaint
    Having problems? Go to our helpdesk?

    Categories